Macrolide treatment failure in a case of secondary syphilis: a novel A2059G mutation in the 23S rRNA gene of Treponema pallidum subsp. pallidum.

Investor logo

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

MATĚJKOVÁ POSPÍŠILOVÁ Petra FLASAROVÁ Magdalena ZÁKOUCKÁ Hana BOŘEK Milan KŘEMENOVÁ Soňa ARENBERGER Petr WOZNICOVÁ Vladana WEINSTOCK G.M. ŠMAJS David

Year of publication 2009
Type Article in Periodical
Magazine / Source Journal of Medical Microbiology
MU Faculty or unit

Faculty of Medicine

Citation
Web http://jmm.sgmjournals.org/cgi/reprint/58/6/832?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Matejkova&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT
Field Microbiology, virology
Keywords penicillin-G benzathine; azithromycin resistance; clinical specimens; isolate; PCR
Description We report an occurrence of treatment failure after oral spiramycin therapy in a man with secondary syphilis and a reported penicillin and tetracycline allergy. Molecular detection revealed treponemal DNA in the blood of the patient and sequencing of the 23S rDNA identified an A to G transition at the gene position corresponding to position 2059 in the Escherichia coli 23S rRNA gene. The occurrence of this novel 23S rDNA mutation was examined among 7 rabbit-propagated syphilitic strains of Treponema pallidum and among 22 syphilis patient isolates from the Czech Republic. The prevalence of A2058G and A2059G mutations among clinical specimens was 18.2 and 18.2 %, respectively.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.